Full Text View
Tabular View
No Study Results Posted
Related Studies
A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies
This study has been completed.
Study NCT00871559   Information provided by Regeneron Pharmaceuticals

First Received on March 25, 2009.   Last Updated on March 24, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
Interventions listed in this trial
Sponsors listed in this trial